These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10476617)

  • 1. Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia.
    Seki H; Kuromaki K; Takeda S; Kinoshita K; Satoh K
    Hypertens Pregnancy; 1999; 18(2):157-64. PubMed ID: 10476617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The possibility of clinical application of the thromboxane A2 synthase inhibitor, ozagrel, for the treatment and prevention of preeclampsia: a preliminary report.
    Seki H; Kuromaki K; Takeda S; Kinoshita K; Satoh K
    J Obstet Gynaecol (Tokyo 1995); 1995 Aug; 21(4):357-65. PubMed ID: 8775905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
    Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
    J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of plasma from women with preeclampsia on endothelial cells activators in vitro].
    Zhou L; Yang M; Li D
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jul; 35(7):401-3. PubMed ID: 11776183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airwayhyperresponsiveness].
    Nishi K; Mizuguchi M; Tachibana H; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):927-33. PubMed ID: 9396248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors.
    Umemura K; Nakashima M; Saruta T
    Life Sci; 1997; 60(18):1583-8. PubMed ID: 9126880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study of relationship between platelet function and thrombus in patients with essential thrombocythaemia].
    Yao HX; Huang L; Lin LE; Wu CM; Wang H; Chen WT; Fu XJ; Ding YP
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):253-5. PubMed ID: 20356540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of stable metabolites of prostacyclin and thromboxane A2 and their ratio in normotensive and preeclamptic pregnant women during the antepartum and postpartum periods.
    Malatyalioğlu E; Adam B; Yanik FF; Kökçü A; Alvur M
    J Matern Fetal Med; 2000; 9(3):173-7. PubMed ID: 10914626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of branch retinal arterial occlusion with sodium ozagrel, a thromboxane A2 synthetase inhibitor.
    Kato H; Emura S; Takeuchi N; Enoki M; Oogushi K; Takashima T; Ohmori K; Saito I
    J Int Med Res; 1997; 25(2):108-11. PubMed ID: 9100166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T; Maeda K; Shibata M; Yamada K
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase].
    Nakazawa M; Iizuka K; Ujiie A; Hiraku S; Ohki S
    Yakugaku Zasshi; 1994 Dec; 114(12):911-33. PubMed ID: 7869235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm.
    Sueda S; Kohno H; Inoue K; Fukuda H; Suzuki J; Watanabe K; Ochi N; Kawada H; Uraoka T
    Circ J; 2002 Sep; 66(9):826-30. PubMed ID: 12224820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor attenuates Nomega-nitro-L-arginine methyl ester-induced preeclampsia-like manifestations in rats.
    Chen D; Wang H; Huang H; Dong M
    Clin Exp Hypertens; 2008 Oct; 30(7):606-15. PubMed ID: 18855264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithromboxane drug in the treatment of preeclampsia.
    Furuhashi N; Tsujiei M; Kimura H; Okamura K; Yajima A
    Gynecol Obstet Invest; 1991; 32(3):164-6. PubMed ID: 1756996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral low-dose magnesium gluconate preventing pregnancy induced hypertension].
    Li S; Tian H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):613-5. PubMed ID: 9642379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ozagrel for Patients With Noncardioembolic Ischemic Stroke: A Propensity Score-Matched Analysis.
    Wada T; Yasunaga H; Horiguchi H; Fushimi K; Matsubara T; Nakajima S; Yahagi N
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2828-2837. PubMed ID: 27567296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
    Ayala DE; Ucieda R; Hermida RC
    Chronobiol Int; 2013 Mar; 30(1-2):260-79. PubMed ID: 23004922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.